Nuzenio

Acquires Prv

Acquires Prv news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 5 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Recon: FDA approves first drug for type 1 narcolepsy, mRNA flu vaccine; No merger talks between AstraZeneca-BMS - RAPSRAPS · Thu, 06 Aug 2026 18:15:00 GMTArrowhead buys PRV for $215M; Twist hopes to raise $300M in public offering - Endpoints NewsEndpoints News · Wed, 05 Aug 2026 14:28:00 GMTARWR: Acquires PRV for sNDA Submission for Plozasiran in sHTG - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 13:38:00 GMTArrowhead acquires FDA priority review voucher for plozasiran's severe hypertriglyceridemia expansion - AllSciAllSci · Wed, 05 Aug 2026 09:58:01 GMTArrowhead Pharmaceuticals Acquires FDA Priority Review Voucher - Arrowhead Pharmaceuticals, Inc.Arrowhead Pharmaceuticals, Inc. · Tue, 04 Aug 2026 20:01:17 GMT

Timeline

Thu, 06 Aug 2026 18:15:00 GMTRecon: FDA approves first drug for type 1 narcolepsy, mRNA flu vaccine; No merger talks between AstraZeneca-BMS - RAPS
Wed, 05 Aug 2026 14:28:00 GMTArrowhead buys PRV for $215M; Twist hopes to raise $300M in public offering - Endpoints News
Wed, 05 Aug 2026 13:38:00 GMTARWR: Acquires PRV for sNDA Submission for Plozasiran in sHTG - Yahoo Finance
Wed, 05 Aug 2026 09:58:01 GMTArrowhead acquires FDA priority review voucher for plozasiran's severe hypertriglyceridemia expansion - AllSci
Tue, 04 Aug 2026 20:01:17 GMTArrowhead Pharmaceuticals Acquires FDA Priority Review Voucher - Arrowhead Pharmaceuticals, Inc.

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Acquires Prv.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.